Literature DB >> 33510484

Refreshing the biologic pipeline 2020.

John Hodgson1.   

Abstract

Entities:  

Year:  2021        PMID： 33510484     DOI： 10.1038/s41587-021-00814-w

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  6 in total

1.  Polymer-Mediated Cryopreservation of Bacteriophages.

Authors:  Huba L Marton; Kathryn M Styles; Peter Kilbride; Antonia P Sagona; Matthew I Gibson
Journal:  Biomacromolecules       Date:  2021-11-30       Impact factor: 6.988

2.  Valuation and Returns of Drug Development Companies: Lessons for Bioentrepreneurs and Investors.

Authors:  Daniel Tobias Michaeli; Hasan Basri Yagmur; Timur Achmadeev; Thomas Michaeli
Journal:  Ther Innov Regul Sci       Date:  2022-01-11       Impact factor: 1.778

3.  Integrated autolysis, DNA hydrolysis and precipitation enables an improved bioprocess for Q-Griffithsin, a broad-spectrum antiviral and clinical-stage anti-COVID-19 candidate.

Authors:  John S Decker; Romel Menacho-Melgar; Michael D Lynch
Journal:  Biochem Eng J       Date:  2022-03-12       Impact factor: 3.978

Review 4.  Nanocarriers for delivery of siRNA as gene silencing mediator.

Authors:  Aideé Morales-Becerril; Liliana Aranda-Lara; Keila Isaac-Olivé; Blanca E Ocampo-García; Enrique Morales-Ávila
Journal:  EXCLI J       Date:  2022-08-01       Impact factor: 4.022

Review 5.  Full-length recombinant antibodies from Escherichia coli: production, characterization, effector function (Fc) engineering, and clinical evaluation.

Authors:  Md Harunur Rashid
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 6.440

6.  Value drivers of development stage biopharma companies.

Authors:  Daniel Tobias Michaeli; Hasan Basri Yagmur; Timur Achmadeev; Thomas Michaeli
Journal:  Eur J Health Econ       Date:  2022-01-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.